- Fourth annual Retail Clinician Education Congress brings together retail healthcare professionals
- Take Care Health Systems teams up with Ochsner Health System
- Most U.S. voters believe an expanded role for nurse practitioners will boost quality of health care
- ACA stands: Supreme Court rules law is a tax
- Walgreens joins CCA
ORLANDO, Fla. — Companies that lower co-payments on prescription drugs while promoting disease management can lower their own healthcare costs, according to a three-year study commissioned by the Florida Health Care Coalition and published in the journal Health Affairs.
The study, which focused on patients with diabetes, found that companies combining disease-management programs with “value-based insurance design” can earn a return of $1.33 for every dollar they spend upfront on medication.
“Amid soaring healthcare costs, this validates that old saying that an ounce of prevention is worth a pound of cure, and that’s especially true where it often hurts most: in our pocketbooks,” FHCC president and CEO Becky Cherney said.